Jiang Xue, Liu Weiwei
Department of Otolaryngology, Cangzhou Central Hospital, Hebei Medical University , Cangzhou, Hebei, China .
DNA Cell Biol. 2017 Jul;36(7):596-602. doi: 10.1089/dna.2017.3686. Epub 2017 Apr 26.
Dysfunction of lncRNA has been found in the nasopharyngeal carcinoma (NPC); however, the effect of lncRNA expression on NPC tumorigenesis as well as the molecular mechanism of lncRNA in the pathogenesis of NPC remain largely unknown. In this study, we showed that highly upregulated in liver cancer (HULC), the first identified lncRNA in hepatocellular carcinoma, is highly expressed in NPC patients and correlated with a poor prognosis of cancer patients. Overexpressed HULC promotes NPC cell growth. Downregulation of HULC activated p53 and induced the increased expression of p21, which finally caused cell cycle arrest and cell apoptosis. These results suggested that HULC acts as an oncogenic lncRNA in NPC and a potential therapeutic target in NPC treatment.
已发现lncRNA在鼻咽癌(NPC)中存在功能障碍;然而,lncRNA表达对NPC肿瘤发生的影响以及lncRNA在NPC发病机制中的分子机制仍 largely未知。在本研究中,我们表明肝癌中高表达的(HULC),即肝细胞癌中首次鉴定出的lncRNA,在NPC患者中高表达,且与癌症患者的不良预后相关。过表达的HULC促进NPC细胞生长。HULC的下调激活了p53并诱导p21表达增加,最终导致细胞周期停滞和细胞凋亡。这些结果表明,HULC在NPC中作为一种致癌lncRNA,是NPC治疗中的一个潜在治疗靶点。